We are developing a value-creating technology platform that combines controlled environment cultivation, genetic engineering, and high-throughput screening to create pharmaceutical drug products and plant protectants.

Our platform enables us to cultivate an extensive range of fungal species. From here, we create a library of secondary metabolites and other fungal-derived compounds and screen them for activity.

With over 6 million different species of fungi worldwide, and only a tiny fraction of these analysed and characterised to date, our programs aim to explore, identify, and harness this immense biodiversity to unlock previously undiscovered, high-value secondary metabolites for use in drug development pipelines.